Sign In
Buy CORT
$72.65
+1.45 (+2.04%)
At Close: Jun 03, 2026
Texas Permanent School Fund Corp Sells 7,613 Shares of Corcept Therapeutics Incorporated $CORT
05:20am, Monday, 22'nd Dec 2025
Texas Permanent School Fund Corp trimmed its position in Corcept Therapeutics Incorporated (NASDAQ: CORT) by 19.4% during the second quarter, according to the company in its most recent 13F filing wit
Corcept Therapeutics Incorporated $CORT Shares Sold by First Trust Advisors LP
04:50am, Wednesday, 10'th Dec 2025
First Trust Advisors LP trimmed its position in Corcept Therapeutics Incorporated (NASDAQ: CORT) by 41.9% during the undefined quarter, according to the company in its most recent filing with the Secu
Cerity Partners LLC Buys 131,799 Shares of Corcept Therapeutics Incorporated $CORT
05:12am, Monday, 08'th Dec 2025
Cerity Partners LLC grew its stake in shares of Corcept Therapeutics Incorporated (NASDAQ: CORT) by 21.4% during the second quarter, according to the company in its most recent disclosure with the SEC
Corcept (CORT) Up 9.2% Since Last Earnings Report: Can It Continue?
12:37pm, Thursday, 04'th Dec 2025
Corcept (CORT) reported earnings 30 days ago. What's next for the stock?
Will Korlym Continue to Drive Corcept's Top Line in 2026?
12:05pm, Monday, 01'st Dec 2025
CORT leans on rising Korlym sales while awaiting key relacorilant FDA decisions that could broaden its growth path in 2026.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Receives Consensus Recommendation of “Hold” from Analysts
03:44am, Saturday, 22'nd Nov 2025
Shares of Corcept Therapeutics Incorporated (NASDAQ: CORT - Get Free Report) have earned an average rating of "Hold" from the seven ratings firms that are presently covering the firm, Marketbeat repor
Envestnet Asset Management Inc. Acquires 7,077 Shares of Corcept Therapeutics Incorporated $CORT
04:34am, Monday, 17'th Nov 2025
Envestnet Asset Management Inc. raised its stake in Corcept Therapeutics Incorporated (NASDAQ: CORT) by 22.3% during the second quarter, according to the company in its most recent Form 13F filing wit
Aviva PLC Trims Holdings in Corcept Therapeutics Incorporated $CORT
04:05am, Friday, 14'th Nov 2025
Aviva PLC trimmed its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ: CORT) by 36.7% in the undefined quarter, according to the company in its most recent Form 13F filing with the Sec
Corcept Q3 Earnings & Revenues Lag Estimates, '25 View Cut, Stock Down
11:06am, Wednesday, 05'th Nov 2025
CORT's third-quarter earnings and sales miss estimate. The company cuts guidance despite a 14% year-over-year rise in revenues.
Corcept Therapeutics Incorporated (CORT) Q3 2025 Earnings Call Transcript
07:26pm, Tuesday, 04'th Nov 2025
Corcept Therapeutics Incorporated ( CORT ) Q3 2025 Earnings Call November 4, 2025 5:00 PM EST Company Participants Atabak Mokari - CFO & Treasurer Gary Robb - Chief Business Officer & Secretary Sean M
Corcept Therapeutics (CORT) Q3 Earnings and Revenues Miss Estimates
07:26pm, Tuesday, 04'th Nov 2025
Corcept Therapeutics (CORT) came out with quarterly earnings of $0.16 per share, missing the Zacks Consensus Estimate of $0.18 per share. This compares to earnings of $0.41 per share a year ago.
Corcept Therapeutics Announces Third Quarter Financial Results, Oncology Development Programs and Provides Corporate Update
04:05pm, Tuesday, 04'th Nov 2025
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinolog
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
04:05pm, Tuesday, 28'th Oct 2025
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced it will report third quarter financial results and provide a corporate update on November 4, 202
Corcept Therapeutics Incorporated $CORT Shares Sold by Cwm LLC
05:00am, Thursday, 23'rd Oct 2025
Cwm LLC trimmed its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ: CORT) by 1.6% in the undefined quarter, according to the company in its most recent 13F filing with the Securities
Corcept Therapeutics Incorporated $CORT Stock Holdings Raised by Sequoia Financial Advisors LLC
04:09am, Thursday, 23'rd Oct 2025
Sequoia Financial Advisors LLC raised its stake in Corcept Therapeutics Incorporated (NASDAQ: CORT) by 8.6% in the undefined quarter, according to its most recent filing with the SEC. The fund owned 3
